Stockpolly
Search
NTHI · NASDAQ · Biotechnology

NeOnc Technologies (NTHI)

Develops intranasal NEO100 and oral NEO212 candidates for brain tumors.

$4.96
At close+0.23 (+4.86%)
Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions22 holders · as of Jun 30, 202616.21%3.16M shares
Insiders8 holders · as of Nov 24, 202547.29%9.21M shares
Otherremainder36.50%7.11M shares

19.47M company shares as of Sep 3, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

Two share counts disagree (19.47M in the company's Sep 3, 2026 report, 25.93M elsewhere); stakes use the report.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Amir F. Heshmatpour1Insiderdirector, 10 percent owner, officer: President
33.40%6.49M13Dfiled Nov 24, 2025 ↗
Cinctive Capital Management LPInstitution
8.25%1.61M13Fas of Jun 30, 2026
Ming-Fu (alan) ChiangInsiderdirector
6.62%1.29MForm 4filed Nov 24, 2025 ↗
Thomas C. ChenInsiderdirector, 10 percent owner, officer: CEO
4.17%812,910Form 4filed May 23, 2025 ↗
Vanguard Capital Management LLCInstitution
2.59%504,17113Fas of Jun 30, 2026
Keithly GarnettInsiderofficer: CFO
1.46%284,953Form 4filed May 23, 2025 ↗
Bank of America Corp /DE/Institution
1.15%224,41213Fas of Jun 30, 2026
Westmount Partners, LLCInstitution
1.01%197,17813Fas of Jun 30, 2026
BlackRock, Inc.Institution
0.92%179,85013Fas of Jun 30, 2026
Geode Capital Management, LLCInstitution
0.85%166,12013Fas of Jun 30, 2026
Yousha Neman-EbrahimInsiderofficer: Chief Clinical Officer
0.69%134,260Form 4filed Nov 24, 2025 ↗
Vanguard Fiduciary Trust CoInstitution
0.47%91,48013Fas of Jun 30, 2026
Patrick WaltersInsiderofficer: COO
0.41%78,885Form 4filed Apr 8, 2025 ↗
Jim DelshadInsiderdirector
0.28%55,310Form 4filed May 19, 2025 ↗
Steven L. GiannottaInsiderdirector
0.26%50,160Form 4filed Mar 28, 2025 ↗
State Street CorpInstitution
0.22%43,17013Fas of Jun 30, 2026
Northern Trust CorpInstitution
0.18%35,87113Fas of Jun 30, 2026
Global Retirement Partners, LLCInstitution
0.14%27,79013Fas of Jun 30, 2026
Marshall Wace, LLPInstitution
0.11%21,78413Fas of Jun 30, 2026
Morgan StanleyInstitution
0.08%15,64713Fas of Jun 30, 2026
Royal Bank of CanadaInstitution
0.08%15,62513Fas of Jun 30, 2026
HCR Wealth AdvisorsInstitution
0.08%15,00013Fas of Jun 30, 2026
Vanguard Global Advisers, LLCInstitution
0.02%4,26513Fas of Jun 30, 2026
Ancora Advisors, LLCInstitution
0.01%2,07513Fas of Jun 30, 2026
Wells Fargo & Company/MNInstitution
0.01%2,00013Fas of Jun 30, 2026
  1. Amir F. Heshmatpour's transaction reports restate only vehicles that traded; the 2025 ownership statement (6.49M) plus the 16.5K net shares acquired since is used instead.

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Jun 30, 2026

22 holders · 3.16M shares · 3 new positions · 13 increased · 4 reduced · 8 closed

HolderShares% outstandingChg q/qFiled
Cinctive Capital Management LP1.61M8.25%+181.9KAug 14, 2026
Vanguard Capital Management LLC504.2K2.59%+288.5KAug 13, 2026
Bank of America Corp /DE/224.4K1.15%−11.0KAug 14, 2026
Westmount Partners, LLC197.2K1.01%+153.9KJul 7, 2026
BlackRock, Inc.179.9K0.92%+24.0KAug 7, 2026
Geode Capital Management, LLC166.1K0.85%+39.3KAug 12, 2026
Vanguard Fiduciary Trust Co91.5K0.47%+35.5KAug 13, 2026
State Street Corp43.2K0.22%0Aug 7, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Amir F. Heshmatpourincl. AFH Holding & Advisory, LLC, HCWG LLC34.30%6.49M13DApr 25, 2025 ↗

Insider tradesForm 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Nov 20, 2025
Yousha Neman-Ebrahimofficer: Chief Clinical Officer
Purchase1,100$6.69134,260
Nov 21, 2025
Amir F. Heshmatpourdirector, 10 percent owner, officer: President
Purchase · 2 lots24,000$6.075,968,000
Nov 24, 2025
Amir F. Heshmatpourdirector, 10 percent owner, officer: President
Purchase6,000$6.512,992,000

CongressHouse and Senate disclosures

Not reported.